Back to search

Article

Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcoma

2020-10-07

Abstract excerpt

Hypoxic regions (habitats) within tumors are heterogeneously distributed and can be widely variant. Hypoxic habitats are generally pan-therapy resistant. For this reason, hypoxia-activated prodrugs (HAPs) have been developed to target these resistant volumes. The HAP evofosfamide (TH-302) has shown promise in preclinical and early clinical trials of sarcoma. However, in a phase III clinical trial, TH-302 did not i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6cc6c05c-887e-517b-9654-3c2117632b8b
DOI
10.1101/2020.10.06.326934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcomaDOI 10.1101/2020.10.06.326934
Select a neighboring publication to make it the new centre.